Skip to main content
. 2018 Sep 27;9(2):58–64. doi: 10.1177/1941874418802061

Table 1.

Patients Characteristics.

Patients Characteristics All Patients With CSF Without CSF P Value (Uncorrected)
No of patients 188 77 111
Age, median (range) 50 (15-92) 54 (16-82) 48 (15-92) .51
Female, n (%) 141 (75%) 63 (81%) 78 (70%) .09
Precipitants of PRES, n (%)
 Hypertension 166 (89%) 69 (87%) 97 (90%) .60
 Immunosuppressiona 66 (34%) 32 (41%) 34 (31%) .17
 Sepsis 31 (16%) 14 (18%) 17 (16%) .70
 Autoimmune disease 25 (13%) 12 (15%) 13 (12%) .50
 Pregnancy/eclampsia 32 (17%) 11 (14%) 21 (19%) .35
 Other thrombotic microangiopathy 11 (6%) 4 (5%) 7 (6%) .70
Symptoms of PRES, n (%)
 Seizure 115 (61%) 49 (62%) 66 (61% .94
 Encephalopathy 108 (58%) 47 (59%) 61 (56%) .68
 Headache 80 (43%) 35 (44%) 45 (42%) .72
 Vision changes 49 (26%) 17 (22%) 32 (29%) .24
 Other 25 (13%) 10 (13%) 15 (14%) .85
Hospital LOS, days, median (range) 10 (2-135) 11 (2-70) 10 (2-135) .67
Hospital disposition, n (%) .87
 Home 120 (64%) 51 (65%) 69 (63%)
 Facility 57 (30%) 23 (30%) 34 (30%)
 Died 9 (5%) 3 (4%) 6 (6%)

Abbreviations: CSF, cerebrospinal fluid; LOS, length of stay; PRES, posterior reversible encephalopathy syndrome.

a Includes immunosuppressive and chemotherapeutic medications